【Germany Archives】
Pharmaceutical giant GlaxoSmithKline has invested $300 million into home DNA testing company 23andMe,Germany Archives allowing it to develop drugs based on human genetics.
The four-year agreement allows GSK access to 23andMe's vast database to accelerate its drug research and development work.
SEE ALSO: The first 3D, full-color X-rays will weird you outMore than 5 million customers use 23andMe's saliva kit to profile their genes. The kits allow users to uncover insights about their ancestry, other people who share your DNA, as well as discover how much of your DNA is Neanderthal.
"We are excited about this unique collaboration as we know that drug targets with genetic validation have a significantly higher chance of ultimately demonstrating benefit for patients and becoming medicines," Hal Barron, GSK's Chief Scientific Officer and president R&D, said in a statement.
23andMe said it already has a portfolio of "early stage" research programmes, which both companies will look to include in the collaboration.
The first project will be a treatment for Parkinson's disease, which currently is in preclinical development. 80 percent of 23andMe's customers have consented to participate in research, and the company said customers are always in control of their information.
"This collaboration will enable us to deliver on what many customers have been asking for -- cures or treatments for diseases," CEO of 23andMe, Anne Wojcicki, added in a statement.
As noted by Reuters, GSK is not the first drug giant to look at modern genetic data, with rivals Roche and AstraZeneca doing the same.
Featured Video For You
This tech designer turned a Gamecube into what?
Search
Categories
Latest Posts
U.N. confirms the ocean is screwed
2025-06-26 11:47Donald Trump refuses to denounce QAnon at NBC town hall
2025-06-26 11:29WWDC 2023: Apple WatchOS 10 is changing how we use our smart watches
2025-06-26 10:57WWDC 2023: Apple announces M2 Ultra chip, its most powerful yet
2025-06-26 09:52This is the fattest of the extremely fat bears
2025-06-26 09:31Popular Posts
NYT Strands hints, answers for May 2
2025-06-26 11:57The San Francisco Zoo's stolen lemur saga gets a weird, happy ending
2025-06-26 11:51A sad day on Pornhub, as Ryan Creamer retires
2025-06-26 10:04NYT mini crossword answers for May 9, 2025
2025-06-26 09:33Featured Posts
Your 'wrong person' texts may be linked to Myanmar warlord
2025-06-26 12:03How to watch HBO's 'The Idol' without cable
2025-06-26 11:35Happy Birthday, Bram Stoker by Sadie Stein
2025-06-26 11:13Spotify cuts 2 percent of its workforce, mainly in podcasts
2025-06-26 10:40Nintendo Switch 2 preorder just days away, per leak
2025-06-26 10:33Popular Articles
Letter from Greenwich Village: Plan B by Brian Cullman
2025-06-26 11:14WWDC 2023: Apple announces M2 Ultra chip, its most powerful yet
2025-06-26 09:38The internet is talking like Kevin from 'The Office' now
2025-06-26 09:37Newsletter
Subscribe to our newsletter for the latest updates.
Comments (919)
Exploration Information Network
Best roborock deal: Save $400 on Q5 Pro+ Robot Vacuum and Mop
2025-06-26 11:47Miracle Information Network
Apple WWDC 2023 keynote livestream: How to watch, start time, streaming info
2025-06-26 11:46Style Information Network
In Proust’s Library by Anka Muhlstein
2025-06-26 10:42Co-creation Information Network
I Sent My Book to David Foster Wallace and All I Got Was This Lousy Postcard by Sadie Stein
2025-06-26 10:40Pursuit Information Network
Waymo data shows humans are terrible drivers compared to AI
2025-06-26 09:51